Both intensity of physical activity and time spent active can explain variability in femoral neck BMD in people with class III obesity.
A femoral stress index assessment evaluates fracture risk in children as effectively as femoral and total body bone mineral density.
In a double-blind multicenter study, researchers examined the safety and efficacy of burosumab for X-linked hypophosphatemia.
Patients treated with zoledronic acid vs oral bisphosphonates had higher risk for heart failure and arrhythmias.
More than 75% of patients in the treatment group experienced a decrease in bone marrow edema.
Intermittent hypoxia in obstructive sleep apnea was found to decrease the chances of bone health decline in menopausal women.
Both anxiety and depression scores are associated with low BMD.
It has been previously reported that parathyroidectomy can reverse cognitive dysfunction associated with primary hyperparathyroidism.
Endocrinology Advisor Articles
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Plasma Methylglyoxal Levels Associated With CVD, Mortality in Type 2 Diabetes
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- AMA: Federal Government Must Tackle Rising Insulin Prices
- Diabetes Medication Reconciliation May Reduce Risk of ED Visits